Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ImmunoGen, Inc. Earnings: What Goes Up, Must Come Down

TheMotleyFool

0 0

ImmunoGen, Inc. Earnings: What Goes Up, Must Come Down

After popping 14% on Friday follow earnings that didn't justify the increase, shares of ImmunoGen (NASDAQ: IMGN) are down 12.6% at 2:49 p.m. EDT on Monday, also for no apparent reason. The biotech reported second-quarter earnings on Friday, but without any revenue-generating drugs on the market, the focus is on the biotech's pipeline rather than the earnings number.

Metric

Q2 2017

Source: Fool.com